DXYZ · Destiny Tech100 Inc. · Stock research

Current Thesis

The scarcity-premium frame that died with SpaceX's June listing has been re-underwritten with a new underlying: Anthropic. The fund closed $34.43 on 2026-08-21 against a last reported NAV of $24.56 per share (2026-03-31) — roughly 40% above the March mark on arithmetic between the two disclosed figures — after trading at an outright discount at $22.51 on 2026-07-28. What changed in between is not a DXYZ disclosure. It is Anthropic: a confidential Form S-1 filed in June 2026, an annualized revenue run rate of $65B in July (up ~600% YoY) and a last private valuation of $965B, all per Motley Fool's 2026-08-20 write-up. Anthropic was ~ at 2026-03-31, the largest single sleeve, and it has no listed proxy. That is the leg being bought: a listed wrapper on a pre-IPO AI lab whose IPO is now being discussed in SpaceX-sized terms. The condition of the trade is unattractive — RSI(14) at 89.6 on 2026-08-21, a price back above the $28.76 average at which the fund issued 8.49M ATM shares in Q1 2026, and a June-30 NAV that has still not printed.

Bullish and bearish views on Destiny Tech100 Inc.

The model's bull view on Destiny Tech100 Inc. (DXYZ), in brief: Anthropic filed confidentially for an IPO in June 2026 and reported a $65B annualized run rate in July, up from $47B in May per the same 2026-08-20 reporting. The bear view: The $1B Jefferies ATM (commission up to 3.0%) is economic again. Both cases follow in full.

Bull Case

• Anthropic filed confidentially for an IPO in June 2026 and reported a $65B annualized run rate in July, up from $47B in May per the same 2026-08-20 reporting. The largest sleeve in the book (~18% at 2026-03-31) is compounding faster than the mark that carries it.
• The last private valuation on that sleeve is $965B (Motley Fool, 2026-08-20). The 2026-03-31 NAV of $24.56 predates both the July run-rate disclosure and the S-1 news flow, so the fund's stated mark is stale against the thing driving the price.
• Third-party capital is chasing the same exposure: Bloomberg reported 2026-08-12 that Lightspeed is seeking $600M for Anthropic and OpenAI wagers. Prediction-market pricing reported 2026-08-21 puts a 72% probability on Anthropic closing its first trading day at or above a $1.8T market cap — an attention observable, not a valuation.
• NAV has compounded through every premium collapse: $6.44 (2024-12-31) → $19.97 (2025-12-31) → $24.56 (2026-03-31).
• The SpaceX sleeve (~16% at 2026-03-31) survived its first supply event. The 2026-08-06 lockup released 911.5M shares, lifting public float from 4.9% to 11.8%, and SPCX closed +6.1% that day.

Bear Case

• The $1B Jefferies ATM (commission up to 3.0%) is economic again. A closed-end fund cannot sell common below NAV without shareholder approval, which is why the shelf sat dormant through July; at $34.43 that constraint is gone. The Q1 2026 precedent is specific: 8.49M shares issued at an average $28.76, roughly $244M net — issuance that capped every 2026 rally.
• The June-30 NAV — the first to mark SpaceX at public prices — has not been published. As of 2026-08-22 no Q2 2026 release appears on the StockTitan DXYZ news feed or stockanalysis.com; the comparable Q2 2025 release was dated 2025-08-08. The market is paying a premium to a mark that is nearly five months old and that the next print could cut.
• SPCX priced at $135 on 2026-06-12, peaked at $225.64 on 2026-06-16, and carries a 52-week low of $104.83, trading below its IPO price into the August unlock. The SpaceX sleeve is the one holding with a live public mark and it has been going the wrong way.
• The Anthropic listing is the same trap that already sprang once. When SpaceX listed, DXYZ's "only way in" argument evaporated within weeks and the fund went from a ~151% premium (2026-05-21) to a discount by 2026-07-28. A successful Anthropic IPO removes the access rationale for the largest sleeve.
• Momentum is stretched against a broken structure: RSI(14) 89.6 at 2026-08-21 while the shares remain 51.7% below the $71.24 adjusted 52-week high, with a three-month price change of −48.3%.

Setup & Price Structure

The August leg is a vertical recovery inside a broken 2026 downtrend, not a base. Reference points: $22.51 close on 2026-07-28 (below the $24.56 NAV), $25.89 on 2026-08-07, roughly $29.65 quoted on 2026-08-11 per stockanalysis.com, and $34.43 on 2026-08-21 with market cap $1.05B on 30.47M shares and an unadjusted 52-week range of $19.71–$72.87. RSI(14) at 89.6 is the pipeline's reading on the adjusted series as of 2026-08-21; it is measuring the violence of a bounce off a deep drawdown rather than confirming trend. There is no consolidation shelf built above $29–$30 yet — the move went through that zone in days.

Crowding and positioning observables, stated as observables: share count has been unchanged at 30.47M from 2026-07-10 through 2026-08-21, so no ATM issuance has yet been observed into this strength — but the price now sits above the $28.76 average of the Q1 2026 issuance, which is the level at which the fund demonstrated willingness to sell stock. DXYZ-specific headlines remain thin; the attention flow sits in Anthropic IPO coverage dated 2026-08-20/21, not in fund news, which means the bid is borrowed. Beta runs near 5.5 across data feeds. A quarterly report and the first public June-30 NAV are both overdue against last year's cadence, so a disclosure event sits inside the next few weeks with no confirmed date.

Catalyst Calendar (next 30 days)

• ~2026-08-29 (est.) — Semi-annual shareholder report for the period ended 2026-06-30. Registered funds transmit semi-annual reports within 60 days of period end, which puts the deadline at approximately this date; last year's June-30 semi-annual report is published on destiny.xyz.
• ~2026-08-31 (est.) — Q2 2026 results press release with 2026-06-30 NAV per share. Already past the prior-year cadence (Q2 2025 results were dated 2025-08-08), so this can land on any day.
• Monthly, undated — Monthly NAV updates. The reference the discount/premium is traded against between quarterly marks.

Elapsed catalysts

• Undated, ongoing — Remaining SPCX lockup tranches (nine total; the first released 2026-08-06). Each release adds float to the sleeve that carries a live public mark. (passed 20d ago)
• No announced date — Anthropic IPO. Confidential S-1 filed June 2026; no public filing or pricing date has been announced as of 2026-08-22. (passed 4d ago)

What Would Change Our Mind

The structure that must hold is the August re-rating itself: the fund went from a discount to a premium in fifteen sessions on external news, with no fund disclosure behind it, so the leg unwinds on the same mechanism. A daily close below $29.50 gives back the entire advance above the 2026-08-11 level near $29.65 and puts price back into the $22.50–$25.89 range that framed late July and early August. Three non-price conditions would do the same work: a 2026-06-30 NAV printed below $24.56 at the pending Q2 report, which would widen the premium against a fresh mark rather than a stale one; a reported share count above 30.47M, showing the Jefferies ATM restarted into the strength as it did in Q1 2026; or the Anthropic listing arriving and compressing the access premium the way SpaceX's 2026-06-12 debut did between May and July. Conversely, a June-30 NAV materially above $24.56 with the share count still at 30.47M would argue the current price is closer to the book than it looks.

Correlation Notes

• SPCX is the only sleeve with a public mark (~16% at 2026-03-31), so DXYZ carries a direct read on SpaceX's post-unlock tape; SPCX's 52-week low is $104.83 and further lockup tranches are undated.
• Anthropic (~18%) and OpenAI (~6%) have no listed proxies, so DXYZ trades as one of the few US-listed wrappers on private AI-lab marks alongside vehicles such as the Fundrise Innovation Fund; flow into those vehicles and DXYZ's premium tend to move together.
• Reported compute arrangements tie the two largest sleeves together: 2026-08-20 coverage describes an Amazon commitment of $100B over ten years and roughly $1.25B per month to SpaceX for compute running to 2029, which means an Anthropic funding shock propagates through the book twice.
• Beta near 5.5 means the fund amplifies the high-beta AI complex in both directions; the 2026 drawdown from $71.24 to $22.51 and the August bounce to $34.43 are the same mechanism.
• Quote and NAV feeds for this name disagree materially. The market-cap-consistent figures ($1.05B on 30.47M shares at 2026-08-21) are the ones used here.